The anti-inflammatory and antifibrotic effects of a novel, pan-phosphodiesterase inhibitor in murine model of allergic asthma
K. Wójcik-Pszczola (Kraków, Poland), K. Pociecha (Kraków, Poland), E. Wyska (Kraków, Poland), G. Chlon-Rzepa (Kraków, Poland), H. Plutecka (Kraków, Poland), M. Zadrozna (Kraków, Poland), B. Nowak (Kraków, Poland), P. Koczurkiewicz-Adamczyk (Kraków, Poland), E. Pekala (Kraków, Poland), R. Gosens (Groningen, Netherlands)
Source: International Congress 2022 – In vivo and in vitro studies of airway diseases
Session: In vivo and in vitro studies of airway diseases
Session type: Thematic Poster
Number: 3158
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Wójcik-Pszczola (Kraków, Poland), K. Pociecha (Kraków, Poland), E. Wyska (Kraków, Poland), G. Chlon-Rzepa (Kraków, Poland), H. Plutecka (Kraków, Poland), M. Zadrozna (Kraków, Poland), B. Nowak (Kraków, Poland), P. Koczurkiewicz-Adamczyk (Kraków, Poland), E. Pekala (Kraków, Poland), R. Gosens (Groningen, Netherlands). The anti-inflammatory and antifibrotic effects of a novel, pan-phosphodiesterase inhibitor in murine model of allergic asthma. 3158
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|